ANGIOGENESIS INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

Background: Angiogenesis inhibitors have become an important therapeutic approach in the treatment of hepatocellular carcinoma (HCC) patients. The achievement of Sorafenib in prolonging overall survival of patients with HCC makes therapeutic inhibition of angiogenesis a fundamental element of the tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Massimiliano Berretta (Author), Luca Rinaldi (Author), Fabrizio Di Benedetto (Author), Arben Lleshi (Author), Valli De Re (Author), Gaetano Facchini (Author), Paolo De Paoli (Author), Raffaele Di Francia (Author)
Format: Book
Published: Frontiers Media S.A., 2016-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available